Pediatric inflammatory bowel disease: specificity of very early onset

Teresa Capriati1, Sabrina Cardile2, Bronislava Papadatou2

  • 1a Artificial Nutrition Unit and Hepato-Metabolic Disease Unit , Pediatric Hospital Bambino Gesu , Rome , Italy.

Insights

Early-onset inflammatory bowel disease (IBD) (<6 years) can stem from genetic defects. Monogenic IBD-like diseases differ from standard IBD in subtypes, sex prevalence, and treatment needs.

Area of Science:

  • Pediatric Gastroenterology
  • Genetics
  • Immunology

Background:

  • Inflammatory bowel disease (IBD) incidence has risen globally.
  • Genetic defects are increasingly linked to early-onset IBD (<6 years).

Purpose of the Study:

  • To review and update knowledge on the specific characteristics of IBD presenting before age six.
  • To differentiate between conventional IBD and monogenic IBD-like diseases in this age group.

Main Methods:

  • Literature review focusing on early-onset IBD (<6 years).
  • Analysis of disease phenotypes, genetic factors, and clinical outcomes.
  • Comparison between monogenic IBD-like diseases and conventional IBD.

Main Results:

  • Females are less frequently affected by monogenic IBD-like disorders, some with X-linked inheritance.
  • Crohn's Disease (CD) subtype suggests monogenic causes, while Unclassified IBD (IBDU) is more common in conventional IBD.
  • Isolated colonic location is prevalent in both IBD subsets at <6 years onset compared to later onset.
  • Monogenic disorders often require aggressive treatment and carry risks of lymphoma.

Conclusions:

  • Early-onset IBD (<6 years) encompasses both standard IBD and distinct monogenic IBD-like conditions.
  • Understanding these differences is crucial for appropriate diagnosis and management.
  • Monogenic IBD-like diseases present unique challenges requiring tailored therapeutic strategies.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
893
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
652
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
3.3K